Renal Final Report - Fall 2020 Cycle 

Renal disease is a leading cause of morbidity and mortality in the United States. More than 37 million adults in the United States (greater than 15 percent of the population) have chronic kidney disease (CKD). Untreated CKD can result in end-stage renal disease (ESRD) and a host of other health complications. Currently, over half a million people in the United States have received a diagnosis of ESRD, which is the only chronic disease covered by Medicare for people under the age of 65. Considering the high mortality rates and high healthcare utilization and costs associated with ESRD, the need to focus on quality measures for patients with renal disease is particularly important. On February 8 and 11, 2021, NQF convened a multi-stakeholder Standing Committee composed of 25 individuals to evaluate one new measure and one measure undergoing maintenance review and make recommendations for endorsement. Neither measure was endorsed.